USA

Predicting Parkinson’s Disease Trajectory using Clinical and Neuroimaging Baseline Measures

Predictive biomarkers of Parkinson’s Disease progression are needed to expedite neuroprotective treatment development and facilitate prognoses for patients. This work uses measures derived from resting-state functional magnetic resonance imaging, including regional homogeneity (ReHo) and fractional amplitude of low frequency fluctuations (fALFF), to predict an individual’s current and future severity over up to 4 years and to elucidate […]

Predicting Parkinson’s Disease Trajectory using Clinical and Neuroimaging Baseline Measures Read More »

Parkinson’s Disease: Possible Mechanisms for Nutritional Approaches

Parkinson’s disease (PD) is among the most common chronic neurodegenerative conditions, affecting 1% of those over 60 years of age, and involves motor and non-motor impairments. Alterations in normal physiology may become apparent years – in some cases, 10–20 years – before established diagnostic criteria are met. Thus, better clinical outcomes may result when practitioners

Parkinson’s Disease: Possible Mechanisms for Nutritional Approaches Read More »